Literature DB >> 31635928

Oncologic Emergencies: The Fever With Too Few Neutrophils.

Brit Long1, Alex Koyfman2.   

Abstract

BACKGROUND: Cancer is associated with a variety of complications, including neutropenic fever, which can result in severe morbidity and mortality. This oncologic emergency requires ED management.
OBJECTIVE: This narrative review provides focused updates for emergency clinicians regarding neutropenic fever. DISCUSSION: Neutropenic fever is defined by fever with oral temperature >38.3°C or temperature >38.0°C for 1 hour with an absolute neutrophil count (ANC) < 1000 cells/microL. Patients who have received chemotherapy within 6 weeks of presentation are at high risk for neutropenia. While most patients with neutropenic fever do not have an identifiable bacterial source of fever, clinicians should treat patients for bacterial infection. Rapid assessment and management are vital to improving outcomes in patients with suspected or confirmed neutropenic fever. History and examination should focus on the most common sites of infection: the gastrointestinal tract, blood, skin, lung, and urinary tract. However, physical examination and laboratory or imaging assessment may not display classic signs of infection. Blood cultures should be obtained, and broad-spectrum antibiotics are recommended. Oncology consultation is an integral component in the care of these patients. Several risk scores can assist in stratifying patients who may be appropriate for discharge home and follow-up.
CONCLUSIONS: Neutropenic fever is an oncologic emergency. Rapid diagnosis and care of patients with neutropenic fever can improve outcomes, along with oncology consultation. Published by Elsevier Inc.

Entities:  

Keywords:  cancer; febrile neutropenia; infection; malignancy; neutropenic fever; therapy

Year:  2019        PMID: 31635928     DOI: 10.1016/j.jemermed.2019.08.009

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  2 in total

1.  The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients.

Authors:  Pungkava Sricharoen; Chaithawat Chueluecha; Chaiyaporn Yuksen; Chetsadakon Jenpanitpong
Journal:  Open Access Emerg Med       Date:  2022-02-05

2.  Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia.

Authors:  Călin Căinap; Sânziana Cetean-Gheorghe; Laura Ancuta Pop; Daniel Corneliu Leucuta; Doina Piciu; Andra Mester; Cătălin Vlad; Crişan Ovidiu; Alexandra Gherman; Cristina Crişan; Alina Bereanu; Ovidiu Bălăcescu; Anne Marie Constantin; Irina Dicu; Loredana Bălăcescu; Adina Stan; Patriciu Achimaş-Cadariu; Simona Căinap
Journal:  Medicina (Kaunas)       Date:  2021-06-30       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.